Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid

BioTechGrid

  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
Posted inBiotechnology

Sleep Duration Linked to Healthy Aging in Seniors

February 22, 2026
Continue Reading
sleep-duration-linked-to-healthy-aging-in-seniors
Posted inBiotechnology

Probiotics and Colchicine Efficacy in PFAPA Patients

February 21, 2026
Continue Reading
probiotics-and-colchicine-efficacy-in-pfapa-patients
Posted inBiotechnology

Metal Hydride Compressor Using Hydrogen Heat Transfer

February 21, 2026
Continue Reading
metal-hydride-compressor-using-hydrogen-heat-transfer
Posted inBiotechnology

Multi-Ancestry GWAS Reveals 140 Hearing Loss Loci

February 21, 2026
Continue Reading
multi-ancestry-gwas-reveals-140-hearing-loss-loci
Posted inBiotechnology

Hearing Loss Prevalence in Iranian Elderly Explored

February 21, 2026
Continue Reading
hearing-loss-prevalence-in-iranian-elderly-explored
Posted inBiotechnology

Safe Ultrasound Opens Brain Barrier via Tight Junctions

February 21, 2026
Continue Reading
safe-ultrasound-opens-brain-barrier-via-tight-junctions
Most Popular Post
exploring-the-future-of-healthcare with-panos-karelis
Posted inArtificial intelligence

Exploring the Future of Healthcare with Panos Karelis

exploring-the-future-of-healthcare with-gordon-wishart,-check4cancer
Posted inArtificial intelligence

Exploring the Future of Healthcare with Gordon Wishart, Check4Cancer

exploring-the-future-of-healthcare with-noam-shomron,-tel-aviv-university
Posted inArtificial intelligence

Exploring the Future of Healthcare with Noam Shomron, Tel Aviv University

exploring-the-future-of-healthcare with-raul-villamarin-rodriguez,-woxsen-university
Posted inArtificial intelligence

Exploring the Future of Healthcare with Raul Villamarin Rodriguez, Woxsen University

ucb’s-orchestra-hits-dud-note:-novartis-partnered-parkinson’s-asset-fails-phase-2
Posted inBiotechnology

UCB’s orchestra hits dud note: Novartis-partnered Parkinson’s asset fails phase 2

December 16, 2024
UCB’s Novartis-partnered investigational small molecule has failed to improve symptoms of Parkinson’s disease in a phase 2a trial. The oral…
Read More
roche-mothballs-another-hemophilia-a-gene-therapy-under-spark-amid-plans-to-debut-new-hematologic-asset
Posted inBiotechnology

Roche mothballs another hemophilia A gene therapy under Spark amid plans to debut new hematologic asset

December 16, 2024
Following the apparent elimination of a late-stage gene therapy study last week, Swiss drug juggernaut Roche has confirmed that it’s…
Read More
candid-therapeutics-unwraps-three-new-collaborations-to-discover-and-develop-t-cell-engager-antibodies
Posted inBiotechnology

Candid Therapeutics unwraps three new collaborations to discover and develop T-cell engager antibodies

December 16, 2024
Candid Therapeutics, a new San Diego biotech bent on becoming a leader in the emerging T-cell engager space, has unwrapped…
Read More
bms-keeps-axing-deals-inked-under-old-leadership,-this-time-culling-cell-therapy-pacts-with-century,-immatics
Posted inBiotechnology

BMS keeps axing deals inked under old leadership, this time culling cell therapy pacts with Century, Immatics

December 16, 2024
Bristol Myers Squibb has terminated cell therapy pacts with two biotechs amid "ongoing portfolio prioritization efforts” within the Big Pharma,…
Read More
reviva’s-antipsychotic-shows-promise-against-schizophrenia-symptoms-in-year-long-study
Posted inBiotechnology

Reviva’s antipsychotic shows promise against schizophrenia symptoms in year-long study

December 16, 2024
In the wake of the approval Bristol Myers Squibb’s Cobenfy, it seems that news has ramped up in the schizophrenia…
Read More
fluid-biomed-raises-$27m-for-its-bioabsorbable-brain-aneurysm-stent
Posted inMedical Technology

Fluid Biomed raises $27M for its bioabsorbable brain aneurysm stent

December 16, 2024
Fluid Biomed has raised $27 million to move forward with the development of its bioabsorbable stent designed to divert blood…
Read More
medtronic’s-latest-ingestible-pillcam-completes-first-patient-gi-procedure
Posted inMedical Technology

Medtronic’s latest ingestible PillCam completes first patient GI procedure

December 13, 2024
Medtronic reported that a patient has completed the first procedure with the latest version of its ingestible camera, used to…
Read More
fda-expands-use-of-j&j’s-impella-heart-pumps-to-pediatric-patients
Posted inMedical Technology

FDA expands use of J&J’s Impella heart pumps to pediatric patients

December 12, 2024
The FDA has opened up the use of Johnson & Johnson’s miniaturized heart pumps to certain pediatric patients, including those…
Read More
multiomics-startup-pleno-raises-$25m-for-commercial-launch,-plucks-new-ceo-from-illumina
Posted inMedical Technology

Multiomics startup Pleno raises $25M for commercial launch, plucks new CEO from Illumina

December 11, 2024
Pleno has plenty to talk about. The multiomics diagnostic startup has raised $25 million ahead of plans to launch its…
Read More
uspstf-endorses-hpv-self-collection-tests-for-cervical-cancer-screening
Posted inMedical Technology

USPSTF endorses HPV self-collection tests for cervical cancer screening

December 11, 2024
The U.S. Preventive Services Task Force (USPSTF) has pitched an update to its national guidelines for cervical cancer screening—including self-collection…
Read More

Posts pagination

Previous page 1 … 1,443 1,444 1,445 1,446 1,447 … 1,452 Next page
You May Have Missed
mainz-biomed-looks-to-shed-coloalert,-shifts-focus-in-us
Posted inMedical Technology

Mainz Biomed looks to shed ColoAlert, shifts focus in US

grail-stock-craters-as-key-nhs-galleri-trial-fails-to-hit-primary-endpoint
Posted inMedical Technology

Grail stock craters as key NHS-Galleri trial fails to hit primary endpoint

study-finds-blood-test-can-predict-age-of-alzheimer’s-onset
Posted inMedical Technology

Study finds blood test can predict age of Alzheimer’s onset

danaher-buys-patient-monitoring-specialist-masimo-in-$9.9b-deal
Posted inMedical Technology

Danaher buys patient monitoring specialist Masimo in $9.9B deal

Privacy Policy    Terms

Scroll to Top